Biomarkers and endpoints for dry AMD trials

被引：0
|
作者：
Sadda, Srinivas R. [1 ,2 ]
机构：
[1] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
991
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Biomarkers as intermediate endpoints in chemoprevention trials: Biological basis of lung cancer prevention
    Papadimitrakopoulou, VA
    Hong, WK
    CLINICAL AND BIOLOGICAL BASIS OF LUNG CANCER PREVENTION, 1998, : 305 - 311
  • [22] Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities
    Dunn, B.
    EJC SUPPLEMENTS, 2010, 8 (02): : 2 - 2
  • [23] Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and Opportunities
    Dunn, Barbara K.
    Jegalian, Karin
    Greenwald, Peter
    CLINICAL CANCER PREVENTION, 2011, 188 : 21 - 47
  • [24] Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age COMMENT
    Cummings, Steven R.
    Kritchevsky, Stephen B.
    GEROSCIENCE, 2022, 44 (06) : 2925 - 2931
  • [25] Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures
    Yehoshua, Zohar
    Rosenfeld, Philip J.
    Albini, Thomas A.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 167 - 180
  • [26] Biomarkers and surrogate endpoints
    Aronson, JK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 491 - 494
  • [27] Rheopheresis™ for Dry AMD
    Boyer, D.
    ISOPT: PROCEEDINGS OF THE 6TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, : 1 - 4
  • [28] Inflammatory Biomarkers for AMD
    Stanton, Chloe M.
    Wright, Alan F.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 251 - 257
  • [29] Clinical trials: Surrogate endpoints or hard endpoints?
    Kuller, LH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 59E - 61E
  • [30] Endpoints in vaccine trials
    Hudgens, MG
    Gilbert, PB
    Self, SG
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (02) : 89 - 114
12345